564 related articles for article (PubMed ID: 26633511)
21. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells.
Gerhard R; Nottrott S; Schoentaube J; Tatge H; Olling A; Just I
J Med Microbiol; 2008 Jun; 57(Pt 6):765-770. PubMed ID: 18480335
[TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
23. Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.
Giry M; Popoff MR; von Eichel-Streiber C; Boquet P
Infect Immun; 1995 Oct; 63(10):4063-71. PubMed ID: 7558320
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
25. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
[No Abstract] [Full Text] [Related]
26. Intrinsic Toxin-Derived Peptides Destabilize and Inactivate
Larabee JL; Bland SJ; Hunt JJ; Ballard JD
mBio; 2017 May; 8(3):. PubMed ID: 28512094
[No Abstract] [Full Text] [Related]
27. Upregulation of the host SLC11A1 gene by Clostridium difficile toxin B facilitates glucosylation of Rho GTPases and enhances toxin lethality.
Feng Y; Cohen SN
Infect Immun; 2013 Aug; 81(8):2724-32. PubMed ID: 23690404
[TBL] [Abstract][Full Text] [Related]
28.
Schweitzer T; Genth H; Pich A
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077344
[No Abstract] [Full Text] [Related]
29. Super toxins from a super bug: structure and function of Clostridium difficile toxins.
Davies AH; Roberts AK; Shone CC; Acharya KR
Biochem J; 2011 Jun; 436(3):517-26. PubMed ID: 21615333
[TBL] [Abstract][Full Text] [Related]
30. Toward a structural understanding of Clostridium difficile toxins A and B.
Pruitt RN; Lacy DB
Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
[TBL] [Abstract][Full Text] [Related]
31. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
Jank T; Giesemann T; Aktories K
Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
[TBL] [Abstract][Full Text] [Related]
32. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
33. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
[TBL] [Abstract][Full Text] [Related]
34. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
[TBL] [Abstract][Full Text] [Related]
35. Time-resolved cellular effects induced by TcdA from Clostridium difficile.
Jochim N; Gerhard R; Just I; Pich A
Rapid Commun Mass Spectrom; 2014 May; 28(10):1089-100. PubMed ID: 24711272
[TBL] [Abstract][Full Text] [Related]
36. On the Potential Significance of the Intrinsically Disordered Regions in the Clostridiodes difficile Toxins A and B.
El Hadidy N; Uversky VN; Sun X
Curr Protein Pept Sci; 2022 Jul; 23(3):192-209. PubMed ID: 35585826
[TBL] [Abstract][Full Text] [Related]
37. Toxin B Variants from
López-Ureña D; Orozco-Aguilar J; Chaves-Madrigal Y; Ramírez-Mata A; Villalobos-Jimenez A; Ost S; Quesada-Gómez C; Rodríguez C; Papatheodorou P; Chaves-Olarte E
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31212980
[No Abstract] [Full Text] [Related]
38. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.
Schirmer J; Aktories K
Biochim Biophys Acta; 2004 Jul; 1673(1-2):66-74. PubMed ID: 15238250
[TBL] [Abstract][Full Text] [Related]
39. The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A.
Olling A; Goy S; Hoffmann F; Tatge H; Just I; Gerhard R
PLoS One; 2011 Mar; 6(3):e17623. PubMed ID: 21445253
[TBL] [Abstract][Full Text] [Related]
40. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
